Your browser doesn't support javascript.
loading
Use of Bone-Modifying Agents Among Medicare Beneficiaries With Multiple Myeloma.
Gupta, Arjun; Wang, Peiqi; Ali, Syed Abbas; Rajkumar, S Vincent; Gyawali, Bishal; Overton, Heidi N; Makary, Martin A.
Afiliação
  • Gupta A; The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Wang P; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Ali SA; The Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.
  • Rajkumar SV; Division of Hematology, Mayo Clinic, Rochester, Minnesota.
  • Gyawali B; Division of Cancer Care and Epidemiology, Department of Oncology, Queen's University, Kingston, Ontario, Canada.
  • Overton HN; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.
  • Makary MA; Division of Surgical Oncology, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
JAMA Oncol ; 6(2): 296-298, 2020 02 01.
Article em En | MEDLINE | ID: mdl-31830210

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Medicare / Denosumab / Benefícios do Seguro / Mieloma Múltiplo Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Medicare / Denosumab / Benefícios do Seguro / Mieloma Múltiplo Limite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: JAMA Oncol Ano de publicação: 2020 Tipo de documento: Article